US Patent Issued to Sunbird Bio on Dec. 9 for "Ex vivo protease activity detection for disease detection/diagnostic, staging, monitoring and treatment" (Massachusetts Inventors)

ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,492,422, issued on Dec. 9, was assigned to Sunbird Bio Inc. (Cambridge, Mass.).

"Ex vivo protease activity detection for disease detection/diagnostic, staging, monitoring and treatment" was invented by Faycal Touti (Belmont, Mass.), Wendy Winckler Adamovich (Melrose, Mass.), Sophie Cazanave (Cambridge, Mass.), Mehar Cheema (Medford, Mass.) and Robert S. Langer (Newton, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application provides compositions and methods for determining a disease or condition in a subject. The method comprises contacting a body fluid with a molecule comprising a reporter thereof and the reported is cleaved by an a...